Sanofi - Yahoo Canada Search Results

Ads
related to: Sanofi
NEXLETOL® (bempedoic acid) - See Data

www.nexlizethcp.com
Explore CLEAR data and analysis. See important safety information and full prescribing information.
Prescribing Information · Efficacy · Sample Request · Co-Pay Program
Dosing & Administration
Efficacy, Safety, and Dosing

Information for HCPs

Request Samples
Get patients started

with a 14-day sample

Resources
More Information

For Your Practice

Co-Pay Program
Resources

to Support Your Patients

Safety
Safety Profile - Learn About

Adverse Patient Reactions

MOA
Mechanism of Action -

Watch A Video To Learn More
See Approved Genmab Medicines - Connect with Medical Affairs

www.us.genmab.com
Access Clinical Research Information and Other Medical Resources From Genmab. Genmab - Dedicated to Supporting Patients and the Medical Professionals who Care for Them.
Sign Up for News · Explore Our Technology · Patient Support Program · Learn How we Work
Types: Partnership Opportunities, Learn About Us, Antibody Science Info
Careers
Pipeline
Sign Up
About Us
HCP Official Site - Are your Patients Using OADs?

www.diabetestreatment-type2.com
Learn About a Treatment Option to Help Patients Uncontrolled on OADs. Find Safety Information and Resources for Patients Uncontrolled on OADs.
Coverage & Savings · Dosing Guide · Prescribing Information · FAQs
Types: Coverage Calculator, Co-Pay Card, Injection Guide, Request Samples
Dosing & Titration
Clinical Trial Results
Patient Brochure
Co-Pay Card
Early Diagnosis Matters - Fabry Treatment Options

rethinkfabry.com
Early Diagnosis and Treatment May Reduce Fabry Symptoms and Slow Disease Progression. Keep Track of Your Symptoms, Take Charge of Your Health, and Find Your Fabry Care Team.

Search results

- EU approves Sanofi's Dupixent for 'smoker's lungs'
  Reuters via Yahoo Finance Canada· 6 days ago
  The EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs, ...
- The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
  Zacks via Yahoo Finance Canada· 1 day ago
  Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
- Sanofi Blockbuster Wins Clearance in Europe for Lung Disease
  Bloomberg· 6 days ago
  Sanofi’s Dupixent was cleared for a chronic lung disorder in the European Union, creating another...
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit
  Bloomberg via Yahoo Finance Canada· 5 days ago
  (Bloomberg) -- Bpifrance SACA is looking at a potential investment in Sanofi SA’s consumer health...
- Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
  Bloomberg via Yahoo Finance Canada· 5 days ago
  (Bloomberg) -- Private equity firms Bain Capital and Cinven are exploring a potential joint bid for...
- Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
  Zacks via Yahoo Finance Canada· 6 days ago
  Regeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
- EU approves Sanofi drug for chronic lung disease
  Medical Xpress· 6 days ago
  The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the...
- These Stocks Are Moving the Most Today: Tesla, Corning, BP, Intel, Nvidia, and More
  Barrons.com· 38 minutes ago
  Tesla shares dip after the stock closes higher for a ninth-straight session, Corning and Intel...
- Sanofi CEO on AI's Impact, Lung Disease Drug Clearance
  Bloomberg· 6 days ago
  Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in...
- Bpifrance eyes investment in Sanofi's consumer health business
  Reuters via Yahoo Finance Canada· 5 days ago
  The French public investment bank is in talks with "many funds" and may team up with the winning bidder for Sanofi's consumer health unit, Gonzalo was quoted as saying. Bpifrance ...